Honoured to be part of the CME collaboration between Solis Breast Care & Surgery Centre and Parkway Cancer Centre together with Siau Wei Tang and Chiung Ing Wong this afternoon at Shangri-La Singapore! We were joined by 120 participants made up of both GPs and specialists in this hybrid session. My talk was titled 'Breast Screening: Answers to Your Patients' FAQs'. I covered the basics of breast screening, various screening modalities and data advocating for the use of DBT and supplemental US in dense breasts commonly seen in our local population. Siau-Wei then explored updates in locoregional therapy of breast cancer including oncoplastic techniques while Chiung Ing shared on the latest in systemic therapy using case-based illustrations. We closed the session with a Q&A segment where the questions asked were overwhelmingly screening and radiology-related - so now I know what other FAQs to add to my next talk! Thanks again to Parkway Cancer Centre for the opportunity to share! #StrongerTogether #SolisBreastCareSG #LumaWomenImagingSG #BreastCare #BreastCancer
Sonia Lee’s Post
More Relevant Posts
-
The sentinel lymph node biopsy (SLNB) is a key procedure in head and neck cancer care. This procedure allows our surgeons to perform precise staging with minimal invasiveness. It starts with lymphoscintigraphy, using a radioactive tracer to identify sentinel nodes - the first likely site of cancer spread. In surgery, a blue dye and gamma probe guide the removal of these nodes. Their analysis by a pathologist is crucial for understanding cancer's spread and shaping treatment plans. SLNB exemplifies advanced surgical precision, reducing extensive lymph node removal and its risks. It's a leap forward in cancer care, providing clarity and hope for patients. Contact us at 773-245-5253 to learn how SLNB can be part of your cancer treatment journey. To find out more, visit our website: https://lnkd.in/en92Rdrj #HeadAndNeckCancer #PrecisionMedicine #OCITreatment #CancerStaging #MinimallyInvasive #PatientCare #CancerJourney #MedicalInnovation #OCICares #HopeInTreatment
To view or add a comment, sign in
-
-
Medical Oncologist and Hematologist at Tehran University of Medical Sciences | Assistant professor Research Institute for Hematology, Oncology & Cell Therapy
Omission of axillary surgery in locally advanced breast cancer. Latest findings from the #SENOMAC trial further indicate this possibility. In addition to the results from previous #ACOSOG_Z0011 and #AMAROS trials, SENOMAC design filled the gap with inclusion of a large sample size, inclusion of various groups (T1-T3; older age patients), and inclusion of patients with macro-metastases. This trial provides robust evidence that the omission of completion axillary-lymph-node dissection is safe in patients with clinically node-negative T1-T3 breast cancer and 1-2 sentinel-node macro-metastases who received adjuvant systemic treatment and radiation therapy according to national guidelines. #Breast_cancer #SENOMAC #Axillary_dissection https://lnkd.in/gB7ds922
To view or add a comment, sign in
-
Please join us at ParkLife Cafe for the last Perc session before the summer break We welcome #everyone whether you stroll in, book in or zoom in Cancer Loyalty Card Study (CLOCS) an observational case-control study of purchase behaviour prior to ovarian cancer diagnosis Partners: Imperial College London (PerC) Presenter: Dr James M Flanagan Department: Faculty of Medicine, Department of Surgery & Cancer Date: 11th July 2024 19:01 until 20:59 The Cancer Loyalty Card Study (CLOCS) is an observational case-control study developed to test this hypothesis. The main results from CLOCS show that purchases of pain and indigestion medication were detected up to 8 months prior to diagnosis for ovarian cancer patients compared with controls. This occurs well in advance of the patient’s self-reported first GP visit approximately 3.5 months prior to diagnosis. https://lnkd.in/ewy_zydc
To view or add a comment, sign in
-
🧡HCD International recognizes January as Cervical Cancer Awareness Month, where we focus on a weekly cervical health and wellness topic. Today, we discuss cervical cancer treatment. 👩⚕️If cervical cancer is detected from an Pap Smear, you will be referred to a gynecologic oncologist for treatment. The stage, including the size and spread of the cancer, and the kind of cervical cancer is used to develop a treatment plan. Treatment may involve a combination of surgery, chemotheraphy, and radiation. Seeing a doctor and getting screened regularly supports early detection and reduces the level of treatment needed. 🔍To learn more about cervical cancer treatment, visit https://lnkd.in/dYFD85Xr #HCDI #HCDInternational #CervicalCancerAwareness #CervicalHealth #CervicalWellness #GynecologicOncologist #CervicalCancerTreatment #EarlyDetection #Screening #HealthEquity #CervicalCancer #CancerTreatment
To view or add a comment, sign in
-
-
February is #OesophagealCancerAwarenessMonth. We recently caught up with David Chuter, who is an oesophageal cancer survivor and Patient Advocate on #CancerGrandChallenges team eDyNAmic. In 2006, Dave was diagnosed with and treated for oesophageal-gastro cancer adenocarcinoma at the junction of the oesophagus and stomach. At the time, there was no support network through which he could connect with other patients, so he co-founded the OG Support Group with his medical team. It facilitates both virtual and face-to-face meetings in the UK for oesophageal cancer patients. Currently, the only “cure” for oesophageal cancer is surgery to remove the oesophagus and all or most of the stomach. Only 30% of patients are at an early stage where surgery is possible, and 70% of patients go straight in palliative or end of life care. eDyNAmiC's work is incredibly important to Dave — especially as he's starting to see the potential of research crossing over to the clinical side to ultimate help identify those at risk, support better treatments and potentially save lives. Learn more about eDyNAmic ▶️ https://bit.ly/3IbS4ax
To view or add a comment, sign in
-
-
More positive news for lung cancer patients. ALK+ UK’s chair and founder, Debra Montague, is enrolled in a pioneering trial into robotic lung cancer treatment led by Professor Pallav Shah at the Royal Brompton Hospital. This innovative procedure integrates diagnosis and treatment into a single session, utilising robotic technology for unparalleled precision. With a robot-guided catheter and advanced 3D lung mapping, this method efficiently and safely targets and eradicates tumours, reducing treatment times and minimising surgical risks. This breakthrough offers new hope and could transform lung cancer care, especially for patients ineligible for traditional surgery. #LungCancer #RoboticSurgery #NSCLC #ALKPositiveLungCancer
To view or add a comment, sign in
-
The treatment for ovarian cancer depends on factors such as the stage of cancer and the patient's overall health. Common treatments include surgery, chemotherapy, targeted therapy. Watch this video to know more about the treatment of ovarian cancer. Feel free to ask your queries about cancer. 📍Dr. Rajat Bajaj Specialist in treating cancer patients at Fortis Hospital, Noida Click here to know more: https://lnkd.in/gSaB3Nr #DrRajatBajaj #Oncologist #OvarianaCancer #OvarianCancerTreatment #CancerPrevention #KnowYourCancer #TopCancers #FightCancer #CancerResearch #EarlyDetection #CancerStatistics #BeatCancer #CancerEducation #LeadingCancers #CancerSurvivor #ScreeningSavesLives #RaiseAwareness #CancerTreatment #Fortishospital #GreaterNoidaWest #Noida #Ghaziabad #DelhiNCR
To view or add a comment, sign in
-
Breast cancer management takes different approaches depending on physical and biological characteristics of the disease, as well as the age, over-all health and personal preferences of the patient. Treatment types can be classified into local therapy (surgery and radiotherapy) and systemic treatment (chemo-, endocrine, and targeted therapies). Local therapy is most efficacious in early stage breast cancer, while systemic therapy is generally justified in advanced and metastatic disease, or in diseases with specific phenotypes. Historically, breast cancer was treated with radical surgery alone. Advances in the understanding of the natural course of breast cancer as well as the development of systemic therapies allowed for the use of breast-conserving surgeries, however, the nomenclature of viewing non-surgical management from the viewpoint of the definitive surgery lends to two adjectives connected with treatment timelines: adjuvant (after surgery) and neoadjuvant (before surgery). #snsinstitutions #snsdesignthinkers #designthinking
To view or add a comment, sign in
-
The annual Multidisciplinary Symposium @GatorCME provides a multidisciplinary overview of the diagnosis and treatment of all stages of breast cancer. Dr. Alastair Thompson, Professor and Chief, Section of Breast Surgery @bcmhouston, discussed the importance of gathering all available information, including molecular data on tumor biology, to make informed treatment decisions for ductal carcinoma in situ (#DCIS) patients. Dr. Thompson highlighted a study published in @JournalCancer demonstrating the #DCISionRT test was prognostic for risk and predicted radiation therapy (RT) benefit for DCIS patients. The study showed that DCISionRT identified a clinically meaningful low-risk group and a group with elevated 10-year risks that received substantial RT benefit. https://bit.ly/3JwxzDu. https://lnkd.in/gBtmMDg6 #bcsm #PreludeDx
To view or add a comment, sign in
-